Novel 2,3,4-benzothiadiazepines-2,2-dioxides and processes for the preparation thereof are disclosed. The compounds influence the central nervous system and may be used to treat or prevent Alzheimer's disease, Parkinson's disease or Huntington's disease, senile dementia not of the Alzheimer's type, vascular dementia, post-stroke dementia, Korsakoff's syndrome, Down's syndrome, schizophrenia, panic disorder, post-traumatic stress disorder, anxiety or depression.
new heterocyclic ring system, 2,3,4‐benzothiadiazepines. Starting from the easily available phthalides, an efficient synthesis of 5‐aryl‐2,3,4‐benzothiadiazepine 2,2‐dioxides is described here. Owing to their close structural similarity to 2,3‐benzodiazepines and 2,3‐benzodiazepine‐4‐ones, two well‐known bioactive compound families, the new derivatives can be of importance in medicinal chemistry.
Thermal Ring Contraction Reactions of 9-Aryl-5<i>H</i>,7<i>H</i>-[1,2,5]thiadiazolo[3,4-<i>h</i>][2,3,4]benzothiadiazepine 6,6-Dioxides. Experimental and Computational Studies for Understanding the Course of the Transformations
7-chloro-substituted 2,3,4-benzothiadiazepine 2,2-dioxide, the formation of sulfone via o-quinodimethane is the preferred pathway from the zwitterion. However, in the case of thiadiazolobenzothiadiazepine 6,6-dioxides it has been found that the ring closure of the zwitterion leading to the formation of sultines was kinetically preferred over the loss of sulfur dioxide leading to o-quinodimethane, which is the key intermediate